ENTITY

Baxter International (BAX US)

47
Analysis
Health CareUnited States
Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company's products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and research laboratories.
more
Refresh
17 May 2024 03:00

Baxter International: Driving Revenue with New Innovations and Competitive Conversions! - Major Drivers

Baxter International's first quarter 2024 earnings report revealed that the company exceeded its guidance for that term, with 2% growth on a...

Logo
138 Views
Share
26 Apr 2023 23:38

Baxter International Inc.: Surviving A Supply Chain Nightmare – Key Drivers

Baxter International's fourth quarter performance fell short of the expectations of its management as well as Wall Street. Foreign exchange losses...

Logo
211 Views
Share
08 Feb 2023 19:47

Syngene International Ltd (SYNG IN): Well-Positioned to Capitalize On Strong Industry Tailwind

Through capacity and capability addition in biologics manufacturing and expansion of commercial API manufacturing, Syngene has expanded...

Logo
343 Views
Share
06 Dec 2022 01:38

Baxter International Inc.: Detailed Credit Analysis & Financial Strength Evaluation Report

Baxter International is a giant within the space of dialysis therapies and other healthcare products. The company's recent financial results have...

Logo
309 Views
Share
06 Dec 2022 01:37

Baxter International Inc.: Initiation of Coverage – Recent FDA Approvals & Other Drivers

This is our first report on Baxter International, one of the largest players in the domain of dialysis therapies and other healthcare...

Logo
318 Views
Share
x